Article
Mutations conferring resistance to human immunodeficiency virus type 1 fusion inhibitors are restricted by gp41 and Rev-responsive element functions.
Journal of virology - 1 Jan 2005
Nameki Daisuke, Kodama Eiichi, Ikeuchi Mieko, Mabuchi Naoto, Otaka Akira, Tamamura Hirokazu, Ohno Mutsuhito, Fujii Nobutaka, Matsuoka Masao
Abstract excerpt
One of the human immunodeficiency virus (HIV) envelope proteins, gp41, plays a key role in HIV fusion. A gp41-derived peptide, T-20, efficiently inhibits HIV fusion and is currently approved for treatment of HIV-infected individuals. Although resistant variants have been reported, the mechanism of the resistance remains to be defined. To elucidate the mechanism in detail, we generated variants resistant to C34, a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
